Skip to content

Clinical trials

Neurofibroma, Plexiform trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurofibroma, Plexiform Clear all

62 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20013
20022
20042
20062
20082
20113
20122
20131
20142
20154
20162
20173
20184
20196
20201
20213
20222
20234
20243
20255
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Active, not recruiting13
Recruiting12
Terminated6
Withdrawn4
Not yet recruiting2
Enrolling by invitation2
Unknown status2
Available1
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)18
AstraZeneca6
Indiana University3
Novartis Pharmaceuticals3
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.3
University of Alabama at Birmingham3
Children's Hospital of Philadelphia2
SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany2
St. Justine's Hospital2
Alexion Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurofibroma, Plexiform62
Neurofibromatosis 143
Neurofibromatoses10
Neurofibroma9
Neoplasms4
Brain Neoplasms3
Neuroblastoma3
Neurofibrosarcoma3
Optic Nerve Glioma3
Precancerous Conditions3

Trials

Showing 51 to 62 of 62. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.